Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Haihe Gao, Lisha Li, Mang Xiao, Yongwei Guo, Yi Shen, Lixin Cheng & Ming Tang. (2018) Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma. Cancer Management and Research 10, pages 5083-5089.
Read now
Read now
Articles from other publishers (19)
Xiu Hong, Yang Li, Qian Lv, Jun An, Ying Liu, Xiuli Wang, Rui Li, Yuqiang Hu & Bing Liu. (2023) Identification of an immune-related genes signature to predict risk of recurrence for patients with laryngeal squamous cell carcinoma. International Journal of Immunopathology and Pharmacology 37, pages 039463202311720.
Crossref
Crossref
Huisheng Li, Chao Wu, Zhenxing Sun, Xin Yu, Weishuai Liu, Dongying Liu & Ping Li. (2023)
DKK1 Impairs the Tumor Response to αPD‐1 Immunotherapy by Inactivating CD8
+
T Cells and Recruiting MDSC Cells in HNSC
. Advanced Therapeutics.
Crossref
Crossref
Lara Alessandrini, Laura Astolfi, Antonio Daloiso, Marta Sbaraglia, Tiziana Mondello, Elisabetta Zanoletti, Leonardo Franz & Gino Marioni. (2023) Diagnostic, Prognostic, and Therapeutic Role for Angiogenesis Markers in Head and Neck Squamous Cell Carcinoma: A Narrative Review. International Journal of Molecular Sciences 24:13, pages 10733.
Crossref
Crossref
Xinyu Ye, Jingwen Liu, Rencui Quan, Yi Lu & Jian Zhang. (2023) DKK1 affects survival of patients with head and neck squamous cell carcinoma by inducing resistance to radiotherapy and immunotherapy. Radiotherapy and Oncology 181, pages 109485.
Crossref
Crossref
Fang Chen, Xin Gong, Meng Xia, Feng Yu, Jian Wu, Chaosheng Yu & Junzheng Li. (2022) The Aging-Related Prognostic Signature Reveals the Landscape of the Tumor Immune Microenvironment in Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology 12.
Crossref
Crossref
Hewen Jiang, Zongkang Zhang, Yuanyuan Yu, Hang Yin Chu, Sifan Yu, Shanshan Yao, Ge Zhang & Bao-Ting Zhang. (2022) Drug Discovery of DKK1 Inhibitors. Frontiers in Pharmacology 13.
Crossref
Crossref
Junichi Mitsuda, Takahiro Tsujikawa, Kanako Yoshimura, Sumiyo Saburi, Masaho Suetsugu, Kayo Kitamoto, Mari Takenaka, Gaku Ohmura, Akihito Arai, Hiroshi Ogi, Kyoko Itoh & Shigeru Hirano. (2021) A 14-Marker Multiplexed Imaging Panel for Prognostic Biomarkers and Tumor Heterogeneity in Head and Neck Squamous Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Anja Kafka, Anja Bukovac, Emilija Brglez, Ana-Marija Jarmek, Karolina Poljak, Petar Brlek, Kamelija Žarković, Niko Njirić & Nives Pećina-Šlaus. (2021) Methylation Patterns of DKK1, DKK3 and GSK3β Are Accompanied with Different Expression Levels in Human Astrocytoma. Cancers 13:11, pages 2530.
Crossref
Crossref
Moon Jong Kim, Yuanjian Huang & Jae-Il Park. (2020) Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views. Cancers 12:12, pages 3638.
Crossref
Crossref
Xingyu Liu, Jiarui Chen, Wei Lu, Zihang Zeng, Jiali Li, Xueping Jiang, Yanping Gao, Yan Gong, Qiuji Wu & Conghua Xie. (2020) Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma. Frontiers in Genetics 11.
Crossref
Crossref
Ilaria Betella, William J. Turbitt, Tomasz Szul, Binghao Wu, Alba Martinez, Ashwini Katre, Jaclyn A. Wall, Lyse Norian, Michael J. Birrer & Rebecca Arend. (2020) Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer. Gynecologic Oncology 157:3, pages 765-774.
Crossref
Crossref
Takatsugu Suzuki, Hiroshi Yamazaki, Kazufumi Honda, Eijitsu Ryo, Akihiro Kaneko, Yoshihide Ota & Taisuke Mori. (2019) Altered DNA methylation is associated with aberrant stemness gene expression in early‑stage HNSCC. International Journal of Oncology.
Crossref
Crossref
Melody Mazon, Valérie Larouche, Maryse St-Louis, Detlev Schindler & Madeleine Carreau. (2018) Elevated blood levels of Dickkopf-1 are associated with acute infections. Immunity, Inflammation and Disease 6:4, pages 428-434.
Crossref
Crossref
Guodong Shi, Jingjing Zhang, Zipeng Lu, Dongfang Liu, Yang Wu, Pengfei Wu, Jie Yin, Hao Yuan, Qicong Zhu, Lei Chen, Yue Fu, Yunpeng Peng, Yan Wang, Kuirong Jiang & Yi Miao. (2017) A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma. Oncotarget 8:67, pages 110849-110860.
Crossref
Crossref
Michael H Kagey & Xi He. (2017) Rationale for targeting the Wnt signalling modulator Dickkopf-1 for oncology. British Journal of Pharmacology 174:24, pages 4637-4650.
Crossref
Crossref
Peter Dovjak, Georg Heinze, Anna Rainer, Wolfgang Sipos & Peter Pietschmann. (2017) Serum levels of Dickkopf-1 are a potential negative biomarker of survival in geriatric patients. Experimental Gerontology 96, pages 104-109.
Crossref
Crossref
Mélody Mazon, Delphine Masi & Madeleine Carreau. (2016) Modulating Dickkopf-1: A Strategy to Monitor or Treat Cancer?. Cancers 8:7, pages 62.
Crossref
Crossref
Scott M. Langevin, Melissa Eliot, Rondi A. Butler, Agnes Cheong, Xiang Zhang, Michael D. McClean, Devin C. Koestler & Karl T. Kelsey. (2015) CpG island methylation profile in non-invasive oral rinse samples is predictive of oral and pharyngeal carcinoma. Clinical Epigenetics 7:1.
Crossref
Crossref
Óscar Aguilera, José Manuel González-Sancho, Sandra Zazo, Raúl Rincón, Agustín F. Fernández, Olga Tapia, Francesc Canals, Beatriz Morte, Vincenzo Calvanese, José L. Orgaz, Núria Niell, Susana Aguilar, José M. Freije, Osvaldo Graña, David G. Pisano, Aurea Borrero, Javier Martínez-Useros, Benilde Jiménez, Mario F. Fraga, Jesús García-Foncillas, Carlos López-Otín, Miguel Lafarga, Federico Rojo & Alberto Muñoz. (2015) Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer. Oncotarget 6:8, pages 5903-5917.
Crossref
Crossref